Cardiovascular disease after renal transplantation is an important problem. Patients after
renal transplantation with low LDL-Levels (<130mg/dl) receive Fluvastatin 80mg/day (or no
medication, to look for the cardiovascular outcome with and without statins.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University Hospital Schleswig-Holstein University of Schleswig-Holstein